Molecular imaging techniques in body imaging

Molecular imaging of the body involves new techniques to image cellular biochemical processes, which results in studies with high sensitivity, specificity, and signal-to-background. The most prevalently used molecular imaging technique in body imaging is currently fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET). FDG PET has become the method of choice for the staging and restaging of many of the most common cancers, including lymphoma, lung cancer, breast cancer, and colorectal cancer. FDG PET has also become extremely valuable in monitoring the response to therapeutic drugs in many cancers. New PET agents, such as fluorothymidine and acetate, have also shown promise in the evaluation of response to therapy and in the staging of prostate cancer. Magnetic resonance (MR) spectroscopy has shown promise in the evaluation of prostate cancer. Breast cancer evaluation benefits from advances in spectroscopic imaging and contrast-enhanced kinetic evaluation of vascular permeability, which is altered in neoplastic processes because of release of angiogenic factors. Superparamagnetic iron oxide (SPIO) particles represent the first of an expanding line of MR contrast agents that target specific cellular processes. SPIO particles have also been used in the evaluation of the cirrhotic liver and at MR lymphangiography.     

Pinhold imaging: utility in testicular imaging in children

Pinhole imaging of the testis was done in ten boys with suspected testicular torsion. In three of the ten cases, pinhold images were easier to interpret than images obtained with a converging collimator. In six of the ten cases, pinhold images were required for interpretation of the study, because converging images could not be interpreted.     

Utility of positron emission tomography-magnetic resonance imaging in musculoskeletal imaging

Differentiation between neoplastic and nonneoplastic conditions magnetic resonance imaging (MRI) has established itself as one of the key clinical tools in evaluation of musculoskeletal pathology. However, MRI still has several key limitations which require supplemental information from additional modalities to complete evaluation of various disorders. This has led to the development hybrid positron emission tomography (PET)-MRI which is rapidly evolving to address key clinical questions by using the morphological strengths of MRI and functional information of PET imaging. In this article, we aim to review physical principles and techniques of PET-MRI and discuss clinical utility of functional information obtained from PET imaging and structural information obtained from MRI imaging for the evaluation of musculoskeletal pathology. More specifically, this review highlights the role of PET-MRI in musculoskeletal oncology including initial diagnosis and staging, treatment planning and post-treatment follow-up. Also we will review utility of PET-MRI in evaluating musculoskeletal infections (especially in the immunocompromised and diabetics) and inflammatory condition. Additionally, common pitfalls of PET-MRI will be addressed.     

Magnetic resonance imaging and diffusion-weighted imaging in methylmalonic acidemia

Methylmalonic acidemia (MMA) is an inborn disorder of amino acid metabolism, often presenting with neurological symptoms. We present the results of magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) of the brain in a 16-month-old male patient with classic neurological and laboratory findings for MMA. MRI demonstrated the hyperintensity within globi pallidi both on T2-weighted image and DWI during the acute episode of metabolic acidosis.     

放射性核素骨显像对骨肿瘤样病变的影像学研究价值

骨肿瘤样病变是在病理、影像及临床表现上与骨肿瘤相似的一类疾病.放射性核素骨显像能够比较清楚地显示全身骨骼的形态及骨骼的血液供应和代谢情况,可以早期发现骨代谢的异常,灵敏度高于其他检查.目前关于骨肿瘤样病变的影像学资料以X射线、CT及MRI多见,该文拟对放射性核素骨显像对骨肿瘤样病变的诊断价值进行综述,旨在初步形成系统认识,以帮助临床医师提高对此类疾病的诊断水平.     

MR多参数联合成像在前列腺癌诊断中的研究进展

前列腺癌近年来在我国男性中的发病率逐步上升,已成为威胁中老年男性健康的重要疾病.MR有着良好的软组织分辨力和多方位成像优势,其多参数联合成像无创性诊断前列腺癌具有较大价值.随着MR技术的进展,扩散加权成像(diffusion weighted imaging,DWI)、扩散张量成像(diffusion tensor imaging,DTI)、扩散峰度成像(diffusion kurtosis imaging,DKI)、基于体素内不相干运动(intravoxel incoherent motion imaging,IVIM)的多b值DWI联合动态增强磁共振成像(dynamic contrast enhanced MRI,DCE-MRI)已经逐步应用于前列腺癌的研究及诊断.     

Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging

Magnetic resonance imaging (MRI) of the liver is slowly transitioning from a problem solving imaging modality to a first line imaging modality for many diseases of the liver. The well established advantages of MRI over other cross sectional imaging modalities may be the basis for this transition. Technological advancements in MRI that focus on producing high quality images and fast imaging, increasing diagnostic accuracy and developing newer function-specific contrast agents are essential in ensuring that MRI succeeds as a first line imaging modality. Newer imaging techniques, such as parallel imaging, are widely utilized to shorten scanning time. Diffusion weighted echo planar imaging, an adaptation from neuroimaging, is fast becoming a routine part of the MRI liver protocol to improve lesion detection and characterization of focal liver lesions. Contrast enhanced dynamic T1 weighted imaging is crucial in complete evaluation of diseases and the merit of this dynamic imaging relies heavily on the appropriate timing of the contrast injection. Newer techniques that include fluoro-triggered contrast enhanced MRI, an adaptation from 3D MRA imaging, are utilized to achieve good bolus timing that will allow for optimum scanning. For accurate interpretation of liver diseases, good understanding of the newer imaging techniques and familiarity with typical imaging features of liver diseases are essential. In this review, MR sequences for a time efficient liver MRI protocol utilizing newer imaging techniques are discussed and an overview of imaging features of selected common focal and diffuse liver diseases are presented.     

Molecular imaging: integration of molecular imaging into the musculoskeletal imaging practice

Chronic musculoskeletal diseases such as arthritis, malignancy, and chronic injury and/or inflammation, all of which may produce chronic musculoskeletal pain, often pose challenges for current clinical imaging methods. The ability to distinguish an acute flare from chronic changes in rheumatoid arthritis, to survey early articular cartilage breakdown, to distinguish sarcomatous recurrence from posttherapeutic inflammation, and to directly identify generators of chronic pain are a few examples of current diagnostic limitations. There is hope that a growing field known as molecular imaging will provide solutions to these diagnostic puzzles. These techniques aim to depict, noninvasively, specific abnormal cellular, molecular, and physiologic events associated with these and other diseases. For example, the presence and mobilization of specific cell populations can be monitored with molecular imaging. Cellular metabolism, stress, and apoptosis can also be followed. Furthermore, disease-specific molecules can be targeted, and particular gene-related events can be assayed in living subjects. Relatively recent molecular and cellular imaging protocols confirm important advances in imaging technology, engineering, chemistry, molecular biology, and genetics that have coalesced into a multidisciplinary and multimodality effort. Molecular probes are currently being developed not only for radionuclide-based techniques but also for magnetic resonance (MR) imaging, MR spectroscopy, ultrasonography, and the emerging field of optical imaging. Furthermore, molecular imaging is facilitating the development of molecular therapies and gene therapy, because molecular imaging makes it possible to noninvasively track and monitor targeted molecular therapies. Implementation of molecular imaging procedures will be essential to a clinical imaging practice. With this in mind, the goal of the following discussion is to promote a better understanding of how such procedures may help address specific musculoskeletal issues, both now and in the years ahead.     

梗阻性脑积水的弥散加权成像及弥散张量成像研究

目的探讨磁共振弥散加权成像(DWI)与弥散张量成像(DTI)对梗阻性脑积水的诊断价值。方法 25例梗阻性脑积水患者和30例志愿者均行3.0T磁共振常规序列以及DWI和DTI扫描,重建出ADC图、MD图、FA图、RA图、VR图及AI图,并对各参数图进行测量和记录,所得数据进行统计学分析。结果 30例志愿者及25例梗阻性脑积水患者分别测量双侧侧脑室周围脑白质、胼胝体膝部及压部区域的ADC、MD、FA、RA、VR及AI进行测量,ADC图中胼胝体膝部两组ADC值差异具有统计学意义(P<0.05),双侧侧脑室外侧脑白质两组所测得MD、FA、VR、AI值均有统计学意义(P<0.05),两组胼胝体压部RA值有统计学差异(P<0.05),两组间胼胝体膝部所有测得DTI各参数值均无统计学差异(P>0.05)。结论 DWI和DTI在脑积水的诊断中具有重要的诊断价值。     

扩散加权成像在乳腺疾病中的临床应用及成像影响因素

扩散加权成像技术可以反映组织细胞内水分子的扩散运动特性,进而对活体组织结构及功能状态进行无创性检测,其在乳腺疾病的鉴别诊断、术前评估、术后复发监测及治疗后反应等诸多方面具有重要价值.就扩散加权成像在乳腺疾病中的临床应用新进展及成像技术因素等予以综述.     

创伤性脑损伤弥散加权及弥散张力成像研究

磁共振弥散加权及弥散张力成像是基于水分子运动的成像技术,提供脑生理或病理状态的信息,为创伤性脑损伤,特别是弥漫性轴索损伤的早期诊断、指导临床治疗及预测预后提供一定信息,作为传统影像学的补充,弥散加权成像及弥散张力成像越来越成为TBI检查的可供选择的有价值的方法。     

Postmortem imaging exposed: an aid in MR imaging of musculoskeletal structures

Objective

To identify factors that influence the quality of postmortem magnetic resonance (MR) images of musculoskeletal (MSK) structures as described in the literature, and to evaluate the extent to which these MR images are affected.

Materials and methods

Four useful studies were retrieved from a PubMed and EMBASE search, covering the literature up to 1 March 2012. Three additional studies were included after a manual search from reference lists.

Results

Four human studies and three animal studies are considered in this review. Postmortem MRI quality can be affected by storage temperature, repeated freezing and thawing and fixation. Provided there was an adequate, but above-freezing storage temperature, postmortem changes in fresh cadavers did not appear to affect the MR image quality of MSK structures up to 14 days after death. Image contrast, signal intensities, and relaxation times are temperature-dependent, regardless of whether the specimen was fresh or postmortem for up to 7 days. Bad image quality can occur owing to accelerated autolysis. Freezing and thawing did not affect image quality, unless repeated too often, or whenever a heating pad was used to speed up the thawing process. Conventional formalin-based fixation leads to swelling of soft tissue and fluid accumulation in joints, and therefore to deteriorated images, with image quality just sufficient to visualize gross anatomy.

Conclusion

Various factors were identified that affect postmortem MR image quality of MSK structures. Postmortem MR image quality was good, except for images of the fixated specimen. Freezing is the preferred method of conservation for specimens that are to be subjected to postmortem MRI.     

Diagnostic significance of interslice gap and imaging volume in body MR imaging

Thin interslice gaps and large imaging volumes are detrimental to MR signal and contrast, especially when the body coil is used. To show the influence of these two factors on fat and water signal and contrast, we performed a series of in vitro experiments. A cylinder filled with water and another filled with oil were imaged transaxially (TR = 2000 msec; TE = 20 and 70 msec) with different interslice gaps (0-150% slice thickness). A series of images was obtained to cover a 40-cm imaging volume. Increasing interslice gap thickness increased water signal without affecting fat signal, resulting in a decrease in fat/water contrast on TE = 20 msec (less T1-weighting) and increasing contrast on TE = 70 msec (more T2-weighting). Contrast nearly doubled when the interslice gap was increased from 10% to 75%. As slices moved away from the central slice, fat and water signals decreased slowly to 12.5 cm off center. Signal loss was significant with offsets greater than 12.5 cm. These results emphasize that to obtain proper contrast on T2-weighted images, the optimal interslice gap should be used and the region of interest should be near the central slice. Otherwise, images should be interpreted with caution.     

Magnetic resonance imaging and computed tomography developments in imaging of venous thromboembolism

Venous thromboembolism (VTE) is a disease that causes high morbidity and mortality in the population. At present the first-line imaging test for a suspected pulmonary embolism (PE) is computed tomography (CT) pulmonary angiography, and ultrasonography is widely used for the diagnosis of deep-vein thrombosis (DVT). Although these modalities are proven to be safe and accurate, unresolved issues remain, such as whether CT scanning in patients with a suspected PE should be extended to the legs. Another issue is the diagnosis of recurrent DVT. Magnetic resonance imaging (MRI) offers a number of advantages in the imaging of VTE. Recent developments of scanning protocols with shorter acquisition times, sometimes complemented by navigator gating or making use of endogenous contrast, offer new perspectives for the use of MRI. This review provides an overview of state of the art MRI techniques for the diagnosis of PE and DVT. Furthermore, the use of new contrast agents such as fibrin labeling to detect thrombi are addressed.